| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/22/2002 | WO2002064616A2 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 08/22/2002 | WO2002064613A1 Genetic therapeutics for obesity and diabetes by targeting cathepsin |
| 08/22/2002 | WO2002064612A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/22/2002 | WO2002064611A1 Compositions and methods relating to breast specific genes and proteins |
| 08/22/2002 | WO2002064559A2 Thrombin inhibitors |
| 08/22/2002 | WO2002064551A1 Hiv protease inhibitors based on amino acid derivatives |
| 08/22/2002 | WO2002064172A2 Fhit gene therapy prevents tumor development in fhit-deficient mice |
| 08/22/2002 | WO2002064171A1 Adenoviral transduction of fragile histidine triad (fhit) into cancer cells |
| 08/22/2002 | WO2002064170A1 A method for treating cancer and increasing hematocrit levels |
| 08/22/2002 | WO2002064169A1 Methods of treating diseases in association with decrease in the expression of aop-1 gene or aop-1 and remedies for the diseases |
| 08/22/2002 | WO2002064165A1 Cell proliferation inhibitors comprising ets transcription factor or gene encoding the same |
| 08/22/2002 | WO2002064164A1 Gm-csf and/or defensin protein expression regulators in epithelial cells comprising ets transcription factor or gene encoding the same |
| 08/22/2002 | WO2002064161A2 Method and compositions for immunization with the pseudomonas v antigen |
| 08/22/2002 | WO2002064160A2 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 08/22/2002 | WO2002064159A1 Remedies for tumor in hematopoietic organs |
| 08/22/2002 | WO2002064158A2 Use of a conjugate of il-6 and the receptor thereof for inducing cellular expression of scf and flt-3l |
| 08/22/2002 | WO2002064157A2 Localized myocardial injection method for treating ischemic myocardium |
| 08/22/2002 | WO2002064156A1 Selective killing of rapidly dividing cells |
| 08/22/2002 | WO2002064155A1 Pharmaceutical composition for prevention and remedy of osteoporosis |
| 08/22/2002 | WO2002064154A2 Methods and compositions for inhibiting hiv-coreceptor interactions |
| 08/22/2002 | WO2002064151A1 Acrochordon alleviation |
| 08/22/2002 | WO2002064150A1 Whitening compositions containing ascomycete derived enzyme |
| 08/22/2002 | WO2002064140A1 Thrombin inhibitors |
| 08/22/2002 | WO2002064139A1 Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity |
| 08/22/2002 | WO2002064132A2 Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
| 08/22/2002 | WO2002064131A2 Inflammation-inhibiting compounds |
| 08/22/2002 | WO2002064129A2 Compositions of biochemical compounds involved in bioenergy metabolism of cells |
| 08/22/2002 | WO2002064127A1 Methods and clinical devices for the inhibition or prevention of mammalian cell growth |
| 08/22/2002 | WO2002064108A2 Delivery of biologically active agents |
| 08/22/2002 | WO2002064106A1 USE OF [η-HYDROXY-N-METHYL-L-LEUCINE9]CYCLOSPORIN A FOR HAIR GROWTH |
| 08/22/2002 | WO2002064104A1 Methods for treating fingernails and toenails |
| 08/22/2002 | WO2002064097A2 Vegf-d expression in brain cancer |
| 08/22/2002 | WO2002064091A2 Melanocortin metallopeptides for treatment of sexual dysfunction |
| 08/22/2002 | WO2002064089A2 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial ib-367 peptides |
| 08/22/2002 | WO2002064085A2 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin |
| 08/22/2002 | WO2002064046A2 A compound and method of treatment for fungal pathologies of the oral cavity |
| 08/22/2002 | WO2002064025A2 Inhibition of atf2 activity to treat cancer |
| 08/22/2002 | WO2002064023A2 Fra-1 expression in brain cancer |
| 08/22/2002 | WO2002064022A2 Therapy for cerebral vasospasm |
| 08/22/2002 | WO2002064021A2 Methods and compositions for control of bone formation via modulation of ciliary neurotrophic factor activity |
| 08/22/2002 | WO2002064014A2 Endomural therapy |
| 08/22/2002 | WO2002063959A1 Methods and compositions for stimulating axon regeneration and prventing neuronal cell degeneration |
| 08/22/2002 | WO2002047534A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/22/2002 | WO2002044325A3 Antisense modulation of src-1 expression |
| 08/22/2002 | WO2002040044A3 Chemoattractant recruitment of dendritic cells for enhancement of immunization |
| 08/22/2002 | WO2002040008A3 Treatment of sexual dysfunction with non peptide bombesin receptor antagonists |
| 08/22/2002 | WO2002038167A3 Use of factor xiii for treating hemophilia b |
| 08/22/2002 | WO2002036170A3 Vector system for transducing the positive neurons |
| 08/22/2002 | WO2002033050A3 Methods and compositions for promoting the maturation of monocytes |
| 08/22/2002 | WO2002026325A3 Restoration of perturbed barrier function by application of antiandrogens |
| 08/22/2002 | WO2002024221A3 Notch receptor agonists and uses |
| 08/22/2002 | WO2002018604A3 Methods and compositions for determining isomerase enzymatic activity |
| 08/22/2002 | WO2002015959A3 Compounds and compositions for delivering active agents |
| 08/22/2002 | WO2002013875A3 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
| 08/22/2002 | WO2002008250A3 Ghrelin antagonists |
| 08/22/2002 | WO2002004486A3 Bi-functional fusion proteins from hirudin and tap |
| 08/22/2002 | WO2002004008A3 Methods of therapy with thrombin derived peptides |
| 08/22/2002 | WO2002002602A3 Slgp protein and nucleic acid molecules and uses therefor |
| 08/22/2002 | WO2002000872A3 Compositions and methods for treating or detecting degenerative diseases of the motor neurons |
| 08/22/2002 | WO2002000233A3 Purging of cells using viruses |
| 08/22/2002 | WO2001096374A3 32252, a human amp-binding family member and uses thereof |
| 08/22/2002 | WO2001092330A3 Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation |
| 08/22/2002 | WO2001087958A3 CRYSTAL STRUCTURE OF WORM NitFhit REVEALS THAT A Nit TETRAMER BINDS TWO Fhit DIMERS |
| 08/22/2002 | WO2001087328A3 Interleukin-1 inhibitors in the treatment of diseases |
| 08/22/2002 | WO2001074903A3 Cd20/ige-receptor like molecules and uses thereof |
| 08/22/2002 | WO2001072775A3 Polynucleotides and polypeptides as well as methods for diagnosing and treating lung cancer |
| 08/22/2002 | WO2001072295A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/22/2002 | WO2001070982A3 Brca-1 regulators and methods of use |
| 08/22/2002 | WO2001042506A9 T1 receptor-like ligand ii and uses thereof |
| 08/22/2002 | WO2001008720A3 Hypocretin and hypocretin receptors in regulation of sleep and related disorders |
| 08/22/2002 | WO2000038706A9 Methods for treating cancer and for mediating chemotaxis of dendritic cells |
| 08/22/2002 | WO2000036092A9 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION |
| 08/22/2002 | WO2000033865A9 Methods of inhibiting ectopic calcification |
| 08/22/2002 | WO2000026247A9 Ikaros isoforms and mutants |
| 08/22/2002 | WO2000023465A9 Methods and reagents for isolating biologically active peptides |
| 08/22/2002 | WO2000023092A9 Contulakin-g, analogs thereof and uses therefor |
| 08/22/2002 | WO2000020449A9 MODIFIED TGF-β SUPERFAMILY PROTEINS |
| 08/22/2002 | WO2000011195A9 C-myc is activated by beta-catenin and tcf-4 |
| 08/22/2002 | WO1999058143A9 Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 08/22/2002 | US20020116728 Transgenic mice containing Kir5.1 inwardly rectifying potassium channel gene disruptions |
| 08/22/2002 | US20020116725 Method to increase cerebral blood flow in amyloid angiopathy |
| 08/22/2002 | US20020116724 Nucleotide sequences codingolypeptide for use in the diagnosis and prevention of psoriasis and venous ulcers |
| 08/22/2002 | US20020116069 Injectable implants for tissue augmentation and restoration |
| 08/22/2002 | US20020115848 IBD-associated microbial nucleic acid molecules |
| 08/22/2002 | US20020115847 Nuclear receptor of given amino acid sequence; receptor modulates 9-cis retinoic acid signalling |
| 08/22/2002 | US20020115844 Novel human lipase and polynucleotides encoding the same |
| 08/22/2002 | US20020115842 Novel human proteases and polynucleotides encoding the same |
| 08/22/2002 | US20020115839 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of cell proliferative, differentiation and migration defects |
| 08/22/2002 | US20020115837 Nucleoide sequences coding protein for use in human therapeutics and diagnostics |
| 08/22/2002 | US20020115831 Cell surface molecule mediating cell adhesion and signal transmission |
| 08/22/2002 | US20020115829 Pathogenic escherichia coli associated protein |
| 08/22/2002 | US20020115825 Peptide for use in the treatment of gastrointestinal inflammation and defects of the blood brain barrier |
| 08/22/2002 | US20020115823 Pentapeptide with specific conformation, its production and use |
| 08/22/2002 | US20020115724 Methods and agents for inhibiting protein aging |
| 08/22/2002 | US20020115695 Combinations of a prostaglandin agonist and a HMG-CoA reductase inhibitor |
| 08/22/2002 | US20020115694 Methods for the treatment and prevention of urinary stone disease |
| 08/22/2002 | US20020115667 Treatment of disorders associated with glycolipid accumulation, such as Niemann-Pick Type C disease by administering an inhibitor of glucosylceramide synthesis, such as N-butyldeoxynojirimycin |
| 08/22/2002 | US20020115652 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 08/22/2002 | US20020115633 Isolated polypeptide with an ability of the Y353 ezrin mutant to induce apoptosis having an amino acid sequence of the Y353 ezrin mutant and also having >7 contiguous amino acids (350-356); antitumor agents |
| 08/22/2002 | US20020115631 Human bad polypeptides, encoding nucleic acids and methods of use |